CROSSBOW

LIVE

Serial Number

97087361

Owner

Crossbow Therapeutics, Inc.

Attorney

Michael R. Graif

First Use Date

Jul 10, 2025

Filing Date

Oct 22, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

CROSSBOW Trademark

Serial Number: 97087361 • Registration: 8042889

CROSSBOW is a trademark filed by Crossbow Therapeutics, Inc. on October 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Crossbow Therapeutics, Inc. (25 trademarks)

1030 Massachusetts Avenue, Suite 210
Cambridge, MA 02138

Entity Type: 03

Legal Representation

Attorney of Record

Michael R. Graif

793 trademarks filed View all →

Correspondence Address

Michael R. Graif Brown Rudnick LLP

7 Times Square

New York, NY 10036

United States

Trademark Details

Filing Date

October 22, 2021

Registration Date

November 25, 2025

First Use Anywhere

July 10, 2025

First Use in Commerce

July 10, 2025

Published for Opposition

September 13, 2022

Goods & Services

Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the prevention and treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations, namely, antivirals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 25, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Nov 25, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Nov 3, 2025 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Nov 3, 2025 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Oct 10, 2025 SUPC

USE AMENDMENT FILED

Sep 28, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 28, 2025 EISU

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Aug 1, 2025 EWAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 1, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 1, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 1, 2025 REAP

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 17, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 17, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 17, 2025 REAP

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 13, 2025 EXRA

SOU EXTENSION 5 GRANTED

Mar 13, 2025 EX5G

SOU EXTENSION 5 FILED

Mar 3, 2025 EXT5

SOU TEAS EXTENSION RECEIVED

Mar 3, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 4, 2024 EXRA

SOU EXTENSION 4 GRANTED

Sep 4, 2024 EX4G

SOU EXTENSION 4 FILED

Sep 4, 2024 EXT4

SOU TEAS EXTENSION RECEIVED

Sep 4, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 5, 2024 EXRA

SOU EXTENSION 3 GRANTED

Mar 4, 2024 EX3G

SOU EXTENSION 3 FILED

Mar 4, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Mar 4, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 13, 2023 EXRA

SOU EXTENSION 2 GRANTED

Sep 11, 2023 EX2G

SOU EXTENSION 2 FILED

Sep 11, 2023 EXT2

SOU TEAS EXTENSION RECEIVED

Sep 11, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 9, 2023 EXRA

SOU EXTENSION 1 GRANTED

Aug 8, 2023 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 7, 2023 AITU

NOTICE OF REVIVAL - E-MAILED

Jun 26, 2023 NREV

SOU EXTENSION RECEIVED WITH TEAS PETITION

Jun 25, 2023 TPEX

PETITION TO REVIVE-GRANTED

Jun 25, 2023 PETG

TEAS PETITION TO REVIVE RECEIVED

Jun 25, 2023 PROA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 15, 2023 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 15, 2023 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 15, 2023 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jun 15, 2023 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jun 15, 2023 COAR

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jun 12, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jun 12, 2023 ABN6

SOU EXTENSION 1 FILED

May 8, 2023 EXT1

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 8, 2022 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 13, 2022 NPUB

PUBLISHED FOR OPPOSITION

Sep 13, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 24, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 9, 2022 CNSA

EXAMINER'S AMENDMENT ENTERED

Aug 8, 2022 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 8, 2022 GNEN

EXAMINERS AMENDMENT E-MAILED

Aug 8, 2022 GNEA

EXAMINERS AMENDMENT -WRITTEN

Aug 8, 2022 CNEA

ASSIGNED TO EXAMINER

Aug 1, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 8, 2021 NWOS

NEW APPLICATION ENTERED

Oct 26, 2021 NWAP

Related Trademarks

More from this Owner

More in Same Class

JOOT

KUMA

BERGENBIO

CH2

LEVADEL

LEITERS